JE, H., JA, K., A, D., D, S., GHL, R., AE, J., . . . MAR, F. (2022). Genome-wide analysis provides genetic evidence that ACE2 influences COVID-19 risk and yields risk scores associated with severe disease. Nature genetics, 54(4), 382. https://doi.org/10.1038/s41588-021-01006-7
Chicago Style (17th ed.) CitationJE, Horowitz, et al. "Genome-wide Analysis Provides Genetic Evidence That ACE2 Influences COVID-19 Risk and Yields Risk Scores Associated with Severe Disease." Nature Genetics 54, no. 4 (2022): 382. https://doi.org/10.1038/s41588-021-01006-7.
MLA (9th ed.) CitationJE, Horowitz, et al. "Genome-wide Analysis Provides Genetic Evidence That ACE2 Influences COVID-19 Risk and Yields Risk Scores Associated with Severe Disease." Nature Genetics, vol. 54, no. 4, 2022, p. 382, https://doi.org/10.1038/s41588-021-01006-7.